•
Jun 30, 2020

Zurn Elkay Q2 2020 Earnings Report

Rexnord's financial performance was affected by the COVID-19 pandemic, but cost management and strategic initiatives helped mitigate the impact.

Key Takeaways

Rexnord Corporation reported net sales of $449 million, a 12% decrease compared to the previous year's June quarter. Net income from continuing operations was $36 million, or $0.29 per diluted share, compared to $49 million, or $0.39 per diluted share, in the year-ago quarter. Adjusted EPS was $0.36, down from $0.48 in the prior year, while Adjusted EBITDA was $103 million, representing 23.0% of net sales.

Net sales decreased by 12% year-over-year, with a 12% decline in core sales.

Net income from continuing operations was $36 million, with diluted EPS of $0.29.

Adjusted EPS was $0.36, compared to $0.48 in the year-ago quarter.

Adjusted EBITDA was $103 million, representing 23.0% of net sales.

Total Revenue
$175M
Previous year: $525M
-66.7%
EPS
$0.3
Previous year: -$0.42
-171.4%
Adjusted EBITDA Margin
23%
Previous year: 21.8%
+5.5%
Net Debt Leverage Ratio
1.9
Gross Profit
$177M
Previous year: $203M
-12.9%
Cash and Equivalents
$353M
Previous year: $224M
+58.1%
Free Cash Flow
$39.1M
Previous year: $52.4M
-25.4%
Total Assets
$3.37B
Previous year: $3.31B
+1.6%

Zurn Elkay

Zurn Elkay

Zurn Elkay Revenue by Segment

Forward Guidance

For the September quarter, the company expects sales to decline between 12% and 17%, total segment Adjusted EBITDA margin to range between 22% and 24%, and corporate expenses to approximate $8 million.

Positive Outlook

  • Cost reduction initiatives implemented
  • Order backlogs heading into the quarter
  • July results
  • Anticipated demand patterns through September

Challenges Ahead

  • Persistent uncertainties created by the COVID-19 pandemic
  • Unknown duration of the COVID-19 pandemic

Revenue & Expenses

Visualization of income flow from segment revenue to net income